Jasper Therapeutics, Inc. (JSPR)
NASDAQ: JSPR · Real-Time Price · USD
5.96
-0.20 (-3.25%)
At close: Feb 21, 2025, 4:00 PM
5.86
-0.10 (-1.68%)
After-hours: Feb 21, 2025, 5:23 PM EST
Jasper Therapeutics Market Cap
Jasper Therapeutics has a market cap or net worth of $89.41 million as of February 21, 2025. Its market cap has decreased by -45.97% in one year.
Market Cap
89.41M
Enterprise Value
-1.02M
1-Year Change
-45.97%
Ranking
Category
Stock Price
$5.96
Market Cap Chart
Since January 10, 2020, Jasper Therapeutics's market cap has decreased from $122.75M to $89.41M, a decrease of -27.16%. That is a compound annual growth rate of -6.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 89.41M | -72.12% |
| Dec 31, 2024 | 320.73M | 264.33% |
| Dec 29, 2023 | 88.03M | 294.73% |
| Dec 30, 2022 | 22.30M | -94.26% |
| Dec 31, 2021 | 388.71M | 210.66% |
| Dec 31, 2020 | 125.13M | 1.93% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |